CenterWatch

Lidoderm Patch (lidocaine patch 5% )

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved June 1999

Specific Treatments:

Neurology

Therapeutic Areas

General Information

Lidoderm Patch has been approved for the treatment of post-herpetic neuralgia.